The "Drug Addiction Treatment Market Report 2025" has been added to ResearchAndMarkets.com's offering.

The "Drug Addiction Treatment Global Market Report 2025" delivers crucial intelligence for strategists, marketers, and senior management, enabling them to evaluate this burgeoning market. It's an essential resource that projects market trends over the next decade and beyond.

The drug addiction treatment market has experienced rapid growth, increasing from $20.81 billion in 2024 to an estimated $22.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.1%. This surge is attributed to the rising prevalence of substance use disorders, the demand for effective treatment options, increased drug dependency, growing awareness about addiction recovery, and the integration of digital and personalized treatment solutions. By 2029, the market is projected to reach $33.17 billion at a CAGR of 9.7%. This growth is driven by the adoption of medication-assisted treatments, behavioral therapies, the expansion of detoxification services, and government initiatives supporting treatment programs. Key trends include advancements in treatment methods and the introduction of non-addictive alternatives.

The increasing prevalence of substance use disorders, driven by stress, mental health challenges, and lifestyle factors, fuels market expansion. These disorders significantly impact individual well-being, underscoring the need for drug addiction treatment that offers medical and psychological interventions. Recent data from the UK's Office for Health Improvement & Disparities (OHID) indicates a rise in adults engaging with drug and alcohol services, highlighting the demand for comprehensive addiction treatment solutions.

Major stakeholders leverage technological innovations, such as telehealth, to improve accessibility and patient engagement. For instance, Jovive Health launched Medication-Assisted Treatment (MAT) services for Opioid Use Disorder (OUD) patients in multiple US states. Their approach includes FDA-approved medications and a range of convenient services to enhance patient-centered care. Similarly, Indivior PLC's acquisition of Opiant Pharmaceuticals Inc. aims to broaden their addiction treatment portfolio and includes the promising investigational therapy OPNT003.

Prominent players in the drug addiction treatment market include Novartis AG, Dr. Reddy's Laboratories Ltd., Acadia Healthcare, Hikma Pharmaceuticals plc, Alkermes plc, Indivior PLC, and others. North America maintained its status as the largest region in the market as of 2024, while Asia-Pacific is expected to be the fastest-growing region. Key regions covered in the analysis include Asia-Pacific, Western Europe, North America, and others, with specific attention to countries such as the USA, UK, China, and India.

The global market faces challenges from shifting trade relations and tariffs, impacting the supply of critical medical devices and pharmaceuticals. These challenges necessitate strategies such as diversifying sourcing and boosting local manufacturing. The market's resilience depends on continuous innovation and adaptation to geopolitical shifts.

The drug addiction treatment sector offers a wide array of services, including counseling, behavioral therapy, telehealth, and more, with significant revenues generated through these services. The market research report provides extensive data, forecasts, and analysis, offering a holistic view of the sector's current status and future prospects.

Report Scope:

Markets Covered:

• Type of Drug Addiction: Opioid, Benzodiazepine, Barbiturate, Others
• Treatment Type: Inpatient, Outpatient, Detoxification, Aftercare, Medication-Assisted Treatment (MAT)
• Route of Administration: Oral, Parenteral, Others
• Distribution Channel: Hospital, Retail, Online Pharmacies, Others
• End-User: Rehabilitation Centers, Hospitals, Clinics, Others

Subsegments:

• Opioid Addiction: Prescription, Synthetic, Heroin
• Benzodiazepine Addiction: Alprazolam, Diazepam, Lorazepam, Clonazepam
• Barbiturate Addiction: Amobarbital, Pentobarbital, Phenobarbital, Secobarbital
• Other Types: Cannabis, Cocaine, Hallucinogen, Inhalant, Stimulant

Key Attributes:

Companies Featured

• Novartis AG
• Dr. Reddy's Laboratories Ltd.
• Acadia Healthcare
• Hikma Pharmaceuticals plc
• Alkermes plc
• Indivior PLC
• Emergent BioSolutions Inc.
• Workit Health
• Rusan Pharma Pvt. Ltd.
• Boulder Care
• Bicycle Health
• Eleanor Health
• Affect Therapeutics
• Forge Health
• Orexo AB
• BioCorRx Inc.
• Kinoxis Therapeutics Pty. Ltd.
• Addinex Technologies Inc.
• PursueCare
• Aliya Health Group

For more information about this report visit https://www.researchandmarkets.com/r/ukbox3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114411625/en/